The feasibility of using pathobiome strains as live biotherapeutic products for human use.
Jin P, Lin X, Xu W, Li K, Zhao X, Guo S, Zhao Z, Jiang L, Liao F, Chang L, Wang M, Liu Y, Huang S, Chen Z, Ji F.
Jin P, et al. Among authors: zhao x.
Imeta. 2024 May 26;3(3):e202. doi: 10.1002/imt2.202. eCollection 2024 Jun.
Imeta. 2024.
PMID: 38898988
Free PMC article.